$30.82
0.190.62%
At close: -
$30.82
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Edgewell Personal Care Analyst Ratings and Price Targets | NYSE:EPC | Benzinga
Edgewell Personal Care Co has a consensus price target of $37.22 based on the ratings of 9 analysts. The high is $43 issued by RBC Capital on February 11, 2025. The low is $28 issued by Barclays on April 11, 2025. The 3 most-recent analyst ratings were released by UBS, Barclays, and Canaccord Genuity on April 17, 2025, April 11, 2025, and February 11, 2025, respectively. With an average price target of $33.33 between UBS, Barclays, and Canaccord Genuity, there's an implied 8.15% upside for Edgewell Personal Care Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Barclays
Canaccord Genuity
RBC Capital
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Edgewell Personal Care
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/17/2025 | Buy Now | 3.83% | UBS | Peter Grom57% | $31 → $32 | Maintains | Neutral | Get Alert |
| 04/11/2025 | Buy Now | -9.15% | Barclays | Lauren Lieberman64% | $30 → $28 | Maintains | Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 29.79% | Canaccord Genuity | Susan Anderson66% | $53 → $40 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | -2.66% | Barclays | Lauren Lieberman64% | $33 → $30 | Maintains | Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 39.52% | RBC Capital | Nik Modi53% | $48 → $43 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 13.56% | Wells Fargo | Chris Carey64% | $37 → $35 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 3.83% | Morgan Stanley | Dara Mohsenian73% | $35 → $32 | Maintains | Underweight | Get Alert |
| 01/17/2025 | Buy Now | 7.07% | Barclays | Lauren Lieberman64% | $36 → $33 | Maintains | Equal-Weight | Get Alert |
| 01/16/2025 | Buy Now | 16.81% | UBS | Peter Grom57% | $40 → $36 | Maintains | Neutral | Get Alert |
| 01/07/2025 | Buy Now | 20.05% | Wells Fargo | Chris Carey64% | $42 → $37 | Maintains | Overweight | Get Alert |
| 11/11/2024 | Buy Now | 16.81% | Barclays | Lauren Lieberman64% | $37 → $36 | Maintains | Equal-Weight | Get Alert |
| 10/16/2024 | Buy Now | 29.79% | Truist Securities | Bill Chappell47% | $50 → $40 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | 20.05% | Barclays | Lauren Lieberman64% | $40 → $37 | Maintains | Equal-Weight | Get Alert |
| 08/07/2024 | Buy Now | 29.79% | Barclays | Lauren Lieberman64% | $41 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/07/2024 | Buy Now | 29.79% | UBS | Peter Grom57% | $42 → $40 | Maintains | Neutral | Get Alert |
| 07/19/2024 | Buy Now | 33.03% | Barclays | Lauren Lieberman64% | $40 → $41 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 29.79% | Barclays | Lauren Lieberman64% | $37 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/09/2024 | Buy Now | 71.97% | Canaccord Genuity | Susan Anderson66% | $52 → $53 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | 20.05% | Barclays | Lauren Lieberman64% | $39 → $37 | Maintains | Equal-Weight | Get Alert |
| 02/08/2024 | Buy Now | 39.52% | Wells Fargo | Chris Carey64% | $40 → $43 | Maintains | Overweight | Get Alert |
| 02/08/2024 | Buy Now | 26.54% | Barclays | Lauren Lieberman64% | → $39 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/16/2024 | Buy Now | 13.56% | Barclays | Lauren Lieberman64% | $32 → $35 | Maintains | Underweight | Get Alert |
| 11/10/2023 | Buy Now | 7.07% | Morgan Stanley | Dara Mohsenian73% | $38 → $33 | Maintains | Underweight | Get Alert |
| 10/12/2023 | Buy Now | 3.83% | Barclays | Lauren Lieberman64% | $37 → $32 | Maintains | Underweight | Get Alert |
| 08/07/2023 | Buy Now | 20.05% | Barclays | Lauren Lieberman64% | $36 → $37 | Maintains | Underweight | Get Alert |
| 07/20/2023 | Buy Now | 16.81% | Barclays | Lauren Lieberman64% | $40 → $36 | Maintains | Underweight | Get Alert |
| 05/12/2023 | Buy Now | 29.79% | Barclays | Lauren Lieberman64% | $38 → $40 | Maintains | Underweight | Get Alert |
| 05/10/2023 | Buy Now | 71.97% | Canaccord Genuity | Susan Anderson66% | $52 → $53 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 23.3% | Morgan Stanley | Dara Mohsenian73% | $35 → $38 | Maintains | Underweight | Get Alert |
| 04/05/2023 | Buy Now | 52.5% | UBS | Peter Grom57% | → $47 | Initiates | → Neutral | Get Alert |
| 02/10/2023 | Buy Now | 23.3% | Barclays | Lauren Lieberman64% | $37 → $38 | Maintains | Underweight | Get Alert |
| 02/09/2023 | Buy Now | 71.97% | RBC Capital | Nik Modi53% | → $53 | Reiterates | → Outperform | Get Alert |
| 02/09/2023 | Buy Now | 68.72% | Canaccord Genuity | Susan Anderson66% | $48 → $52 | Maintains | Buy | Get Alert |
| 11/17/2022 | Buy Now | 55.74% | Canaccord Genuity | Susan Anderson66% | → $48 | Initiates | → Buy | Get Alert |
| 11/14/2022 | Buy Now | 13.56% | Barclays | Lauren Lieberman64% | $31 → $35 | Maintains | Underweight | Get Alert |
| 11/11/2022 | Buy Now | 13.56% | Morgan Stanley | Dara Mohsenian73% | $36 → $35 | Maintains | Underweight | Get Alert |
| 11/11/2022 | Buy Now | 42.76% | Wells Fargo | Chris Carey64% | $43 → $44 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 39.52% | Wells Fargo | Roger Read62% | $46 → $43 | Maintains | Overweight | Get Alert |
| 10/26/2022 | Buy Now | 36.28% | Goldman Sachs | Jason English55% | $47 → $42 | Downgrade | Buy → Neutral | Get Alert |
| 10/17/2022 | Buy Now | 16.81% | Morgan Stanley | Dara Mohsenian73% | $40 → $36 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 08/08/2022 | Buy Now | 7.07% | Barclays | Lauren Lieberman64% | $29 → $33 | Maintains | Underweight | Get Alert |
| 08/03/2022 | Buy Now | 42.76% | Wells Fargo | Chris Carey64% | $39 → $44 | Maintains | Overweight | Get Alert |
| 05/12/2022 | Buy Now | -5.91% | Barclays | Lauren Lieberman64% | $34 → $29 | Maintains | Underweight | Get Alert |
| 05/11/2022 | Buy Now | 26.54% | Morgan Stanley | Dara Mohsenian73% | $43 → $39 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | 26.54% | Wells Fargo | Chris Carey64% | $43 → $39 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Edgewell Personal Care (EPC) stock?
The latest price target for Edgewell Personal Care (NYSE:EPC) was reported by UBS on April 17, 2025. The analyst firm set a price target for $32.00 expecting EPC to rise to within 12 months (a possible 3.83% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Edgewell Personal Care (EPC)?
The latest analyst rating for Edgewell Personal Care (NYSE:EPC) was provided by UBS, and Edgewell Personal Care maintained their neutral rating.
When was the last upgrade for Edgewell Personal Care (EPC)?
The last upgrade for Edgewell Personal Care Co happened on February 8, 2024 when Barclays raised their price target to $39. Barclays previously had an underweight for Edgewell Personal Care Co.
When was the last downgrade for Edgewell Personal Care (EPC)?
The last downgrade for Edgewell Personal Care Co happened on October 26, 2022 when Goldman Sachs changed their price target from $47 to $42 for Edgewell Personal Care Co.
When is the next analyst rating going to be posted or updated for Edgewell Personal Care (EPC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edgewell Personal Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edgewell Personal Care was filed on April 17, 2025 so you should expect the next rating to be made available sometime around April 17, 2026.
Is the Analyst Rating Edgewell Personal Care (EPC) correct?
While ratings are subjective and will change, the latest Edgewell Personal Care (EPC) rating was a maintained with a price target of $31.00 to $32.00. The current price Edgewell Personal Care (EPC) is trading at is $30.82, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
